Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Dhingra Kapil Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2023 4 Dhingra Kapil (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
04/04/2023 4 Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 25,200 options to buy @ $17.66, valued at $445k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 16,500 options to buy @ $18.26, valued at $301.3k
06/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2021 4 Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.
Txns: Disposed/sold 25,000 options to buy @ $37.99, valued at $949.8k
Disposed/sold 10,000 options to buy @ $29.8, valued at $298k
Disposed/sold 10,000 options to buy @ $17.27, valued at $172.7k
Disposed/sold 15,000 options to buy @ $6.09, valued at $91.4k
Disposed/sold 20,000 options to buy @ $4.14, valued at $82.8k
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/22/2021 4 Dhingra Kapil (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 29,842 options to buy @ $27.45, valued at $819.2k
01/22/2021 3 Dhingra Kapil (Director) has filed a Form 3 on Black Diamond Therapeutics, Inc.
12/09/2020 4 Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 24,675 shares @ $45.09, valued at $1.1M
Sold 13,523 shares @ $46.22, valued at $625k
Sold 1,802 shares @ $47.04, valued at $84.8k
Exercised 40,000 options to buy @ $1.75, valued at $70k
05/15/2020 4 Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.
Txns: Granted 20,000 options to buy @ $4.14, valued at $82.8k
04/02/2020 4 Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 16,500 options to buy @ $9.78, valued at $161.4k
06/12/2019 4 Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
Txns: Granted 15,000 options to buy @ $6.09, valued at $91.4k
04/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2018 4 Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 13,500 options to buy @ $15, valued at $202.5k
07/19/2018 3 Dhingra Kapil (Director) has filed a Form 3 on Replimune Group, Inc.
05/14/2018 4 Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
Txns: Granted 10,000 options to buy @ $17.27, valued at $172.7k
05/12/2017 4 Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
Txns: Granted 10,000 options to buy @ $29.8, valued at $298k
05/23/2016 4 Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
06/27/2011 4 Dhingra Kapil (Director) has filed a Form 4 on MICROMET, INC.
Txns: Granted 25,000 options to buy @ $5.53, valued at $138.3k
06/24/2010 4 Dhingra Kapil (Director) has filed a Form 4 on MICROMET, INC.
Txns: Granted 15,000 options to buy @ $6.89, valued at $103.4k
06/19/2009 4 Dhingra Kapil (Director) has filed a Form 4 on MICROMET, INC.
02/24/2009 4 Dhingra Kapil (Director) has filed a Form 4 on MICROMET, INC.
02/24/2009 3 Dhingra Kapil (Director) has filed a Form 3 on MICROMET, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy